ArticleBreast cancer research and treatment2024

Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.

María Gion et al.PubMed ↗Publisher ↗

No numbers read from the abstract.